INC Research(R) Appoints Hans J. Moebius as Senior Vice President of CNS Division for Europe.RALEIGH, N.C. -- INC Research([R]), a therapeutically focused contract research organization with a trusted process for delivering reliable results, has named Hans J. Moebius, M.D., Ph.D., as Senior Vice President of its central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) business for Europe. In this position, Dr. Moebius will be responsible for the operations, strategic planning and corporate development of INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. Research's European CNS business and will have management oversight for all CNS and Pediatrics research staff and clinical trials taking place in Europe. Dr. Moebius will also oversee INC Research's expansion into Switzerland and will serve as head of the INC Research Zurich office, which opens in January 2007. Dr. Moebius has more than 16 years of strategic drug development experience in Europe, the United States and Japan and has personally overseen the development of NCEs in epilepsy, Parkinson's disease, depression, Alzheimer's disease and vascular dementia, ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) Definition Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by distractibility, hyperactivity, impulsive behaviors, and the inability to remain focused on tasks or , spasticity spasticity /spas·tic·i·ty/ (spas-tis´i-te) the state of being spastic; see spastic (2). spas·tic·i·ty n. 1. A spastic state or condition. 2. Spastic paralysis. , neuropathic pain, chronic pain, and addiction. He has worked with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , EMEA (Europe, Middle East, Africa) Refers to that region of the world. For example, one might see products packaged differently for the UK, EMEA and Asia Pacific markets. and several national authorities for the successful registration of five new CNS therapies including all aspects of pre-clinical and clinical development, regulatory strategy and establishing global pharmacovigilance strategies. Dr. Moebius will play a leading role in INC's Product Development Services (PDS (1) (Processor Direct Slot) A single expansion slot on certain, early Macintosh models that was used to connect high-speed peripherals as well as additional CPUs. Providing a channel directly to the CPU, the PDS coexisted with NuBus slots on some models. ) group providing CNS drug development consultancy to INC's pharmaceutical customers. "Dr. Moebius is an exceptional addition to our international CNS team," said Kelvin Logan, Ph.D., President of INC Research, Europe. "As we look to further solidify and expand our presence within the European CRO market, Dr. Moebius' substantial clinical and management expertise will be extremely beneficial in continuing to establish INC Research as an industry leader globally." Before joining INC Research, Dr. Moebius served for 10 years with Merz Pharmaceuticals, for the last five years as Chief Scientific Officer and Managing Director. He was responsible for the supervision of seven different departments and hundreds of employees, establishing the company's CNS drug development pipeline and managing international drug development programs and partnerships. Prior to that, he served for five years as senior vice president, global research and development and drug regulatory affairs. Dr. Moebius has won a number of professional distinctions, including heading up the team that won the German Industry Innovation Award for the international development of memantine in late-stage Alzheimer's disease (2002). He is currently a member of the European College of Neuropsychopharmacology, the German Society of Pharmaceutical Physicians, the American Academy of Neurology The American Academy of Neurology (AAN) is a professional society for neurologists and neuroscientists. As a medical specialty society it was established in 1949 by A.B. Baker of the University of Minnesota to advance the art and science of neurology, and thereby promote the best and the German Society for Neurology. He has participated in the international working group for the development of anti-dementia guidelines and is a founding member of the American Society for Experimental Neurotherapeutics and the Swiss Association of Pharmaceutical Physicians. Dr. Moebius earned a bachelor's of science degree in chemistry from the University of Kaiserslautern The University of Kaiserslautern (German Technische Universität Kaiserslautern) is a university located in Kaiserslautern, Germany. It was founded in 1970 and is organized in 10 Faculties. and a doctorate degree in experimental pharmacology from the University of Heidelberg. He is a board certified psychiatrist and neurologist who completed his medical studies at the Universities of Heidelberg and Frankfurt in Germany. He holds the Swiss Degree in Pharmaceutical Medicine. About INC Research([R]) INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase 1 - Phase 4 programs in therapeutic areas of specialty, and in innovative pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. trials. Our "Trusted Process[TM]" methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina For other uses of this name, see Raleigh. Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County. , and in 21 locations in 30 countries worldwide. For more information, please visit our website at www.incresearch.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion